Aruna Dontabhaktuni, Ph.D,

Founder & CEO at PharmaPro Consulting
  • Claim this Profile
Contact Information
Location
New York City Metropolitan Area
Languages
  • English Native or bilingual proficiency
  • Hindi Native or bilingual proficiency
  • Sanskrit Limited working proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 2 ratings
  • (2)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

Gabriele Disselhoff

I have worked with Aruna and I got to know her as knowledgeable and pleasant person to work with. We worked closely on a European PIP, where her PK modeling skills were instrumental in optimal dose dose discussion and regimen selection; in addition, her extensive experience in authoring and reviewing clinical pharmacology regulatory submission documents was very helpful. She is a motivated and experienced drug development executive and has supported several development programs simultaneously.

LinkedIn User

I strongly recommend Aruna for her PK/PD as well as M and S expertise. She has greatly assisted us at Daiichi Sankyo in several active projects by helping us finalize numerous clinical study reports as well as contributed to section 2.7.2 of CTD. Her diverse skills sets and experience in clinical drug development are commendable and can bring value to any organization.

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Founder & CEO
      • Sep 2014 - Present

      Pharmaceutical Professional:Regulatory Affairs | Pharmacometrics | DMPK | Clinical Pharmacology Responsibilities: • Working with clients like Genentech, Roche, Daiichi Sankyo, GlaxoSmithKline, Mabion S.A. (Poland), ContraFect Corporation, SK Life Sciences, Rafael Pharmaceuticals etc. • Author the clinical pharmacology sections for submission to FDA, PMDA, SFDA, EMA, KFDA etc. which include - eCTDs modules 2.7.1 and 2.7.2 - Question-based Review (QbR) - Clinical study protocol - Clinical study reports (CSR) - Investigational New Drug (IND) Application - New Drug Application (NDA) - Pediatric Investigation Plan (PIP), - Pediatric Study Plan (PSP) - Orphan Drug Designation application (ODD) - Breakthrough Therapy Designations application • Help address questions relating to Clinical pharmacology, PK, PK/PD and POPPK from various regulatory agencies across the world. • Developed strategy and execute clinical pharmacology plans, PIP Binding elements and PSP plans • Serve as clinical pharmacology project leader & provide scientific leadership on Biologics, ADC’s and combination therapies, in oncology, immuno-oncology, diseases with unmet medical needs etc. • Based on project needs conduct hands on PK, PK/PD analysis, conducted QC-QR of IB’s, CSR’s, health authority submission documents. • Participate in due-diligence and in-licensing activities. Show less

    • United States
    • Higher Education
    • 1 - 100 Employee
    • Founder & Scientific Director,
      • Jul 2019 - Present

      This is nonprofit organization created to support upcoming scientists from around the world in field of drug development and other healthcare related fields. The objective of this project is to guide them and empower them in achieving their carrier goals, By providing them free workshops/trainings and giving them access to mentoring programs. Our goal is to match the mentors to the mentee based on what mentee’s are seeking to learn and what mentor can offer based on mutual areas of interest, educational background/training and time of availability. Show less

    • United States
    • Higher Education
    • 1 - 100 Employee
    • Adjunct Professor
      • Aug 2021 - Present
    • United States
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • ISoP Communications Committee (Volunteer)
      • Jan 2021 - Present
    • United States
    • Non-profit Organizations
    • 1 - 100 Employee
    • ASCPT Biologics Community Chair (Volunteer)
      • Apr 2021 - Present

    • ASCPT Early Career Steering Committee Member (Volunteer)
      • Apr 2021 - Present

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Director, Global PKPD and Pharmacometrics
      • Mar 2012 - Aug 2014
    • Associate Director Clinical Pharmacokinetics
      • Jan 2010 - Feb 2012

    • Senior Scientist Pharmacokinetics
      • 2008 - Jan 2010

    • United Kingdom
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Scientist Pharmacokinetics
      • 2007 - 2008
    • United States
    • Higher Education
    • 700 & Above Employee
    • Research Fellow
      • Apr 2003 - Jun 2006
    • Senior Scientist, Clinical Pharmacokinetics
      • 2006 - 2006
    • Research Fellow
      • 2003 - 2003
    • Switzerland
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Research Fellow
      • 2002 - 2002

Education

  • Babson College
    Goldman Sachs 10,000 Small Businesses, Entrepreneurship/Entrepreneurial Studies
    2021 - 2021
  • Landmark
    Landmark Graduate, Personal Awareness and Self-Improvement
    2016 - 2019
  • Long Island University
    Doctor of Philosophy (Ph.D.), Pharmaceutical Sciences
    1999 - 2005
  • Gulbarga University
    Bachelor of Pharmacy - BPharm
    1990 - 1994

Community

You need to have a working account to view this content. Click here to join now